Profit before exceptional items and tax increased 17.09% YoY to Rs 153.01 crore, while the company also reported an exceptional loss of Rs 6.41 crore during the quarter.
EBITDA stood at Rs 239.7 crore in Q4 FY26, registering a growth of 10% compared with Rs 217.9 crore in Q4 FY25. EBITDA margin declined by 20 basis points to 18.1% in Q4 FY26, as against 18.3% in Q4 FY25.
For the full financial year FY26, the company reported an 84.52% tumble in net profit to Rs 556.19 crore, compared with Rs 556.19 crore in the previous year. Revenue from operations rose 6.42% to Rs 4,858.68 crore in FY26.
For the full year, the company's US market revenue stood at Rs 2,489.7 crore, growing 2% year-on-year, while Ex-US market revenue rose sharply by 21% to Rs 2,240.4 crore, emerging as the key growth driver for the business.
The company reported net debt of Rs 1,436.5 crore, impacted by forex depreciation of Rs 111.5 crore. Net debt-to-EBITDA improved to 1.55x in FY26 from 1.9x in FY25, while RoCE rose to 15.8% from 14.9%.
Badree Komandur, MD & Group CEO, said, 'Strides continued to deliver strong performance across profitability, efficiency, and growth metrics during FY26. This was primarily driven by the Ex‑US markets, which recorded a growth of 21% YoY. Our continued focus on profitability drove gross margin expansion of 310bps YoY and EBITDA margin improvement of 140bps YoY to 19%. Operational PAT and EPS grew by 50% YoY, reflecting strong operating leverage. Our calibrated strategy in Ex‑US markets is delivering results, with these markets outpacing overall company growth. The US business remained stable during the year, though impacted by a weaker flu season in the second half. Despite ongoing geopolitical uncertainties and a challenging external environment, we are committed to delivering to long term sustainable and profitable growth.'
Meanwhile, the company's board has recommended a final dividend of Rs 5 per equity share of face value Rs 10 each, representing 50% of the face value, for the financial year ended 31 March 2026. The record date for determining shareholders eligible for the dividend will be fixed and intimated in due course. The dividend, subject to shareholders' approval at the ensuing annual general meeting (AGM), will be paid within 30 days from the date of approval after deduction of applicable tax at source.
Strides Pharma Science is a global pharmaceutical company headquartered in Bangalore, India. It develops and manufactures a wide range of niche and technically complex pharmaceutical products.
The counter shed 0.32% to Rs 1,150 on the BSE.
Powered by Capital Market - Live News
Beware of fraudulent tips, unauthenticated news and advice on stock market.
At BOB Capital, your account security is our topmost priority. Beware of receiving fraudulent communications, unauthenticated trading tips and unsolicited calls on trading in stocks from unverified sources, received through Whatsapp, Telegram, SMS, Calls, etc and take an informed decision before investing.
What should you do if you receive a trading tip over phone or SMS?
Report unsolicited messages to the Stock Exchange on +91 8291833676 or on designated email id i.e. feedbk_invg@nse.co.in. Please visit here to understand better.
Please visit CVC website at pledge.cvc.nic.in and take "Integrity Pledge" to be an active part of the "Satark Bharat, Samriddh Bharat" (Vigilant India, Prosperous India).
Filing complaints on SCORES - Easy & quick: a. Register on SCORES portal scores.sebi.gov.in/ b. Mandatory details for filing complaints on SCORES are i. Name, PAN, Address, Mobile Number, E-mail ID. c. Benefits: i. Effective communication ii. Speedy redressal of the grievances.
Valued Customer,
BOB Capital Markets Limited (BOBCaps) is firmly committed to the safety of your wealth. We would like to bring to your notice certain precautions that you certainly must take against potential tele-fraudsters/ unscrupulous and unregistered portfolio managers:
ALWAYS AVOID
We would like to caution you against such fraudulent calls and SMSes and urge you to be alert. Follow the golden rule:
Do not share your Login Credentials or Passwords with anybody
BOBCaps employees / representatives never ask for your password.
Certain tele-fraudsters / unscrupulous and unregistered portfolio managers call customers or SMS them on the pretext of providing investment tips and lure them to invest through their bogus firms by promising huge profits.
Such deceitful callers ask the customer to share his/her login credentials with passwords to allow trading in their accounts, assuring huge returns.
Often trades done in the customer’s accounts are far from the best interest of the customers. Holdings of customers are often sold and with the funds, trades are then placed in illiquid securities at unrealistic prices.
At times, the holdings of customers are sold at prices detrimental to the customer. The so-called “portfolio manager” assures profits, which naturally does not materialize. Customers are deceived into providing access to their trading accounts, thereby allowing such fraudsters access to funds and securities available to execute trades, injurious to the customer’s interest.
In our continuous effort to keep you safeguard from the market related frauds and increase awareness while conducting trades, we request you to go through the Press Release issued by the NSE and would request you to ensure that you do not engage with the individuals and entities mentioned below: